Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1476
Real REMAX Group Inc. Common Stock
REAX
$341M
| $5.39M | 0.01% |
119,591
+34,881
| +41% | +$1.5M |
2023 Q3
7 quarters
|
|
1477
Consensus Cloud Solutions
CCSI
$673M
| $5.37M | 0.01% |
232,900
+56,200
| +32% | +$1.21M |
2021 Q4
14 quarters
|
|
1478
Vir Biotechnology
VIR
$1.98B
| $5.37M | 0.01% |
1,064,500
-55,900
| -5% | -$300K |
2021 Q4
14 quarters
|
|
1479
Avista
AVA
$2.97B
| $5.36M | 0.01% |
141,300
+36,600
| +35% | +$1.44M |
2024 Q4
2 quarters
|
|
1480
Gentherm
THRM
$1.62B
| $5.36M | 0.01% |
189,464
+125,400
| +196% | +$3.33M |
2025 Q1
1 quarter
|
|
1481
Advance Auto Parts
AAP
$2.55B
| $5.36M | 0.01% |
+115,250
| New | +$4.62M |
2025 Q2
0 quarters
|
|
1482
Columbia Banking Systems
COLB
$8.03B
| $5.36M | 0.01% |
229,096
-142,600
| -38% | -$3.31M |
2025 Q1
1 quarter
|
|
1483
Del Monte Corp
DMC
$1.39B
| $5.35M | 0.01% |
165,000
-100,300
| -38% | -$3.3M |
2014 Q3
43 quarters
|
|
1484
StoneX
SNEX
$7.39B
| $5.35M | 0.01% |
131,996
-10,926
| -8% | -$411K |
2022 Q2
12 quarters
|
|
1485
DELISTED
ODP
ODP
| $5.34M | 0.01% |
+294,792
| New | +$4.62M |
2025 Q2
0 quarters
|
|
1486
Allient
ALNT
$1.87B
| $5.34M | 0.01% |
147,072
+3,900
| +3% | +$108K |
2013 Q2
48 quarters
|
|
1487
Cognyte Software
CGNT
$651M
| $5.34M | 0.01% |
577,711
-61,900
| -10% | -$609K |
2022 Q1
13 quarters
|
|
1488
Reynolds Consumer Products
REYN
$4.64B
| $5.32M | 0.01% |
248,400
+31,100
| +14% | +$704K |
2021 Q4
14 quarters
|
|
1489
West Pharmaceutical
WST
$25.8B
| $5.32M | 0.01% |
+24,300
| New | +$5.19M |
2025 Q2
0 quarters
|
|
1490
Farmland Partners
FPI
$457M
| $5.31M | 0.01% |
461,000
+259,500
| +129% | +$2.78M |
2024 Q4
2 quarters
|
|
1491
Cummins
CMI
$72.1B
| $5.31M | 0.01% |
16,200
-21,900
| -57% | -$6.78M |
2025 Q1
1 quarter
|
|
1492
MannKind Corp
MNKD
$1.06B
| $5.28M | 0.01% |
1,412,942
-236,803
| -14% | -$1.04M |
2024 Q2
4 quarters
|
|
1493
Dolby
DLB
$5.5B
| $5.24M | 0.01% |
70,600
+66,600
| +1,665% | +$4.99M |
2025 Q1
1 quarter
|
|
1494
Under Armour Class C
UA
$2.05B
| $5.24M | 0.01% |
807,300
-1,401,400
| -63% | -$8.27M |
2020 Q1
21 quarters
|
|
1495
Bioventus
BVS
$892M
| $5.24M | 0.01% |
790,818
+237,318
| +43% | +$1.68M |
2023 Q3
7 quarters
|
|
1496
Orthofix Medical
OFIX
$374M
| $5.23M | 0.01% |
469,201
+377,211
| +410% | +$4.67M |
2013 Q2
48 quarters
|
|
1497
Arcosa
ACA
$7.23B
| $5.23M | 0.01% |
60,300
-2,400
| -4% | -$201K |
2025 Q1
1 quarter
|
|
1498
i-80 Gold Corp
IAUX
$1.38B
| $5.22M | 0.01% |
8,723,031
+4,671,834
| +115% | +$2.75M |
2024 Q2
4 quarters
|
|
1499
Relay Therapeutics
RLAY
$3.92B
| $5.22M | 0.01% |
1,508,210
-767,900
| -34% | -$2.28M |
2023 Q3
7 quarters
|
|
1500
NEOS S&P 500 High Income ETF
SPYI
$12.5B
| $5.22M | 0.01% |
103,700
+77,100
| +290% | +$3.71M |
2023 Q3
7 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.